Skip to main content

Observational: Time & Motion (CA209-1573)

Trial ID
N/A
Trial Sponsor
BMS and OnCare

Observational Time and Motion Study of Nivolumab Intravenous vs. Nivolumab in combination with hyaluronidase (Subcutaneous) in a Real-World Community Oncology Setting

Is your health insurance changing in 2026? Be sure to bring your new card in for our records!

X